INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 19, 2014 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
Feb 19, 2014 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 10,000 |
Feb 19, 2014 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 1,620 |
Feb 13, 2014 |
Director
Trans History: 368
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 2,500 |
Feb 13, 2014 |
Director
Trans History: 368
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 2,500 |
Feb 13, 2014 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 20,000 |
Feb 13, 2014 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,568 |
Feb 13, 2014 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,623 |
Feb 12, 2014 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Other acquisition or disposition | -- | -- | 4,098 |
Feb 12, 2014 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 69,960 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.